The Effect of a Synthetic Estrogen, Ethinylestradiol, on the hERG Block by E-4031

Inhibition of K+-conductance through the human ether-a-go-go related gene (hERG) channel leads to QT prolongation and is associated with cardiac arrhythmias. We previously reported that physiological concentrations of some estrogens partially suppress the hERG channel currents by interacting with the S6 residue F656 and increase the sensitivity of hERG blockade by E-4031. Although these studies suggested that clinically used synthetic estrogens with similar structures have the marked potential to alter hERG functions, the hERG interactions with synthetic estrogens have not been assessed. We therefore examined whether ethinylestradiol (EE2), a synthetic estrogen used in oral contraceptives, affects hERG function and blockade by drugs. Supratherapeutic concentrations of EE2 did not alter amplitudes or kinetics of the hERG currents elicited by train pulses at 20 mV (0.1 Hz). On the other hand, EE2 at therapeutic concentrations reduced the degree of hERG current suppression by E-4031. The administration of EE2 followed by E-4031 blockade reversed the current suppression, suggesting that the interaction of EE2 and E-4031 alters hERG at the drug-binding site. The effects of EE2 on hERG blockade raised the possibility that other estrogens, including synthetic estrogens, can alter hERG blockade by drugs that cause QT prolongation and ventricular arrhythmias.

[1]  D. Trégouët,et al.  Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women , 2018, JAMA cardiology.

[2]  Kevin R. DeMarco,et al.  A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal‐induced arrhythmias , 2017, The Journal of physiology.

[3]  Beiyan Zou,et al.  Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay , 2016, Acta Pharmacologica Sinica.

[4]  N. Harada,et al.  Aromatase knockout mice reveal an impact of estrogen on drug-induced alternation of murine electrocardiography parameters. , 2015, The Journal of toxicological sciences.

[5]  T. Furukawa,et al.  Sex and gender aspects in antiarrhythmic therapy. , 2012, Handbook of experimental pharmacology.

[6]  T. Furukawa,et al.  A receptor-independent effect of estrone sulfate on the HERG channel. , 2009, Journal of pharmacological sciences.

[7]  N. Harada,et al.  Acute effects of oestrogen on the guinea pig and human IKr channels and drug‐induced prolongation of cardiac repolarization , 2008, The Journal of physiology.

[8]  Ken Asada,et al.  Progesterone Regulates Cardiac Repolarization Through a Nongenomic Pathway: An In Vitro Patch-Clamp and Computational Modeling Study , 2007, Circulation.

[9]  T. Saikawa,et al.  Influence of Menstrual Cycle on QT Interval Dynamics , 2006, Pacing and clinical electrophysiology : PACE.

[10]  J. Nerbonne,et al.  Molecular physiology of cardiac repolarization. , 2005, Physiological reviews.

[11]  T. Furukawa,et al.  Nontranscriptional Regulation of Cardiac Repolarization Currents by Testosterone , 2005, Circulation.

[12]  M. W. van den Heuvel,et al.  Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. , 2005, Contraception.

[13]  P. Greenland,et al.  Estrogen and Progestin Use and the QT Interval in Postmenopausal Women , 2004, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[14]  R. Kass,et al.  K+ channel structure-activity relationships and mechanisms of drug-induced QT prolongation. , 2003, Annual review of pharmacology and toxicology.

[15]  M. Hiraoka,et al.  Effects of Na+ Channel Blocker, Pilsicainide, on HERG Current Expressed in HEK‐293 Cells , 2003, Journal of cardiovascular pharmacology.

[16]  Mirei Nagai,et al.  Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency. , 2003, Cardiovascular research.

[17]  J. Herman,et al.  Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. , 2001, Regulatory toxicology and pharmacology : RTP.

[18]  J. Pezzullo,et al.  Drug-induced QT prolongation in women during the menstrual cycle. , 2001, JAMA.

[19]  S. Priori,et al.  Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias , 2000, Journal of cardiovascular electrophysiology.

[20]  M. Lazdunski,et al.  Involvement of IsK-associated K+ channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome. , 1998, Circulation research.

[21]  M. Lehmann,et al.  Sex difference in risk of torsade de pointes with d,l-sotalol. , 1996, Circulation.

[22]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[23]  M. Lehmann,et al.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. , 1993, JAMA.